Exercise-induced Bronchoconstriction
📧 Sign up to get email alerts when something new happens for Exercise-induced Bronchoconstriction.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2021-02-22FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Singulair (montelukast sodium) filed by Organon LLC, resulting in changes to the product lab…
-
FDA label_change · 2016-12-13FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) by Organon LLC, resulting in updated labeling for the product.
-
FDA label_change · 2014-11-26FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a labeling supplemental application for Singulair (montelukast) submitted by Organon LLC.
-
FDA label_change · 2013-03-21FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) from Organon LLC, resulting in a labeling change for the product.
-
FDA label_change · 2011-06-10FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast) submitted by Organon LLC, likely affecting labeling and/or indications.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2010-04-26FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Singulair (montelukast) from Organon LLC, indicating a labeling change associated with the p…
-
FDA label_change · 2010-04-26FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair to update labeling; Organon LLC submitted the request.
-
FDA label_change · 2009-01-27FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application to update the labeling for Singulair (montelukast) under Organon LLC.
-
FDA label_change · 2007-04-13FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC. The approval updates the drug's labelin…